Sameer Ullah Khan
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 4
- Oncology 12
- Cancer Cells and Metastasis 5
- Cancer-related Molecular Pathways 4
- Co-authors
- Kaneez Fatima (8 shared papers)Fayaz Malik (5 shared papers)Shariqa Aisha (3 shared papers)Fayaz Malik (12 shared papers)Abubakar Wani (8 shared papers)Kaneez Fatima (3 shared papers)Halime Kalkavan (1 shared paper)Sandip B. Bharate (2 shared papers)
- Journals
- Medical Oncology (2 papers)Clinical and Experimental Medicine (1 paper)Combinatorial Chemistry & High Throughput Screening (1 paper)Current Molecular Medicine (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Sameer Ullah Khan
29 papers receiving 758 citations
Sameer Ullah Khan's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 138
- Oncology 188
- Molecular Biology 329
- Pharmacology 63
- Toxicology 13
Countries citing papers authored by Sameer Ullah Khan
This map shows the geographic impact of Sameer Ullah Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Ullah Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Ullah Khan more than expected).
Fields of papers citing papers by Sameer Ullah Khan
This network shows the impact of papers produced by Sameer Ullah Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Ullah Khan. The network helps show where Sameer Ullah Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameer Ullah Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unveiling the mechanisms and challenges of cancer drug resistance Hit paper breakdown → | 2024 | 208 |
| 2 | 2021 | 127 | |
| 3 | 2022 | 84 | |
| 4 | 2023 | 66 | |
| 5 | 2022 | 33 | |
| 6 | 2023 | 24 | |
| 7 | 2019 | 24 | |
| 8 | 2021 | 23 | |
| 9 | 2022 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2022 | 14 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2024 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2024 | 6 | |
| 20 | 2024 | 5 |
About Sameer Ullah Khan
Sameer Ullah Khan is a scholar working on Molecular Biology, Oncology, Epidemiology, Pharmacology and Immunology, having authored 30 papers that have together received 765 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Autophagy in Disease and Therapy (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (2 papers), Biosensors and Analytical Detection (2 papers), Phytochemistry and Biological Activities (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (188 citations), Molecular Biology (329 citations), Pharmacology (63 citations) and Toxicology (13 citations). Sameer Ullah Khan has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Kaneez Fatima, Fayaz Malik, Shariqa Aisha, Fayaz Malik, Abubakar Wani, Kaneez Fatima, Halime Kalkavan, Sandip B. Bharate, Damir Huremović and Utpal Nandi. Their work appears in journals such as Medical Oncology, Clinical and Experimental Medicine, Combinatorial Chemistry & High Throughput Screening, Current Molecular Medicine and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.